HNGE
Hinge Health, Inc.
NYSE: HNGE · HEALTHCARE · HEALTH INFORMATION SERVICES
$65.34
+0.91% today
Updated 2026-06-12
Market cap
$5.06B
P/E ratio
—
P/S ratio
7.82x
EPS (TTM)
$-8.91
Dividend yield
—
52W range
$30 – $67
Volume
1.3M
WallStSmart proprietary scores
36
out of 100
Grade: D
Sell
Investment rating
7.3
Growth
B+5.0
Quality
C+3.5
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-2.7
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$67.40
+3.15%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
7 Strong Buy8 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $43.00M — positive
+ Revenue growth 47.20% QoQ
+ Debt/equity 0.02x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -2.69 — distress zone
- Thin margins at -78.90%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|
| Revenue | $292.73M | $390.40M | $587.86M | $646.34M | $1.0B |
| Net income | $-108.14M | $-11.93M | $-528.26M | $35.13M | — |
| EPS | — | — | — | $-8.91 | $2.45 |
| Free cash flow | $-68.52M | $45.23M | $170.73M | $43.00M | — |
| Profit margin | -36.94% | -3.06% | -89.86% | -78.90% | — |
Peer comparison
Smart narrative
Hinge Health, Inc. trades at $65.34. Our Smart Value Score of 36/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -2.69, it sits in the distress. TTM revenue stands at $646.34M. with profit margins at -78.90%.
Frequently asked questions
What is Hinge Health, Inc.'s stock price?
Hinge Health, Inc. (HNGE) trades at $65.34, on a P/S of 7.8x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Hinge Health, Inc. overvalued?
Hinge Health, Inc. carries a Smart Value Score of 36/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Hinge Health, Inc. (HNGE)?
The 12-month analyst consensus target is $67.40, about 3.2% above the current $65.34. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of HNGE by 2030?
Our research-backed model puts the 2030 base case at $242.31, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is Hinge Health, Inc.'s revenue?
Hinge Health, Inc.'s trailing twelve-month revenue is $646.34M, and our model projects it reaching about $2.21B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Hinge Health, Inc.'s Altman Z-Score is -2.69, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio7.82x
ROE-197.22%
Beta—
50D MA$50.53
200D MA$47.62
Shares out0.05B
Float0.04B
Short ratio—
Avg volume1.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—